Neostigmine Methyl Sulfate: Your Trusted Pharmaceutical Raw Material
Discover the high-purity solution for advanced medical and research applications.
Get a Quote & SampleProduct Core Value

Neostigmine Methyl Sulfate
This high-grade pharmaceutical raw material, identified by CAS 51-60-5, is a critical compound for numerous medical treatments and research initiatives. Its meticulously controlled production ensures exceptional purity and adherence to stringent USP standards, making it a reliable choice for critical applications.
- As a pharmaceutical raw material, Neostigmine Methyl Sulfate is essential for developing advanced therapeutics.
- The confirmed high purity of Neostigmine Methyl Sulfate USP Standard guarantees reliable results in critical applications.
- This red powder form of Neostigmine Methyl Sulfate is easy to handle and incorporate into various formulations.
- Leverage our expertise in sourcing buy neostigmine methyl sulfate raw material for your pharmaceutical needs.
Key Advantages
Exceptional Purity
Benefit from the guaranteed 99.50% assay of our Neostigmine Methyl Sulfate, ensuring optimal performance in sensitive pharmaceutical processes.
USP Compliance
Our product meets rigorous USP standards, providing confidence and compliance for your drug development and manufacturing.
Versatile Application
Whether for research or therapeutic applications, this high purity neostigmine methyl sulfate serves as a versatile chemical for various medical formulations.
Key Applications
Neuromuscular Blockade Reversal
Used to counteract the effects of neuromuscular blocking agents in surgical anesthesia, a key area for pharmaceutical chemical development.
Myasthenia Gravis Treatment
A crucial component in managing Myasthenia Gravis, this compound supports the improvement of muscle strength and function.
Ogilvie Syndrome Management
Effectively used in the treatment of Ogilvie syndrome, aiding in the restoration of normal bowel function.
Research and Development
Serves as a vital tool for researchers exploring new therapeutic avenues related to cholinergic systems and acetylcholinesterase inhibition.